It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
WASHINGTON — Just two weeks after pleading guilty in a major federal fraud case, Amgen, the world’s largest biotechnology firm, scored a largely unnoticed coup on Capitol Hill: Lawmakers inserted a paragraph into the “fiscal cliff” bill that did not mention the company by name but strongly favored one of its drugs.
Senators Max Baucus, left, and Orrin Hatch, in June at a Finance Committee meeting, have received contributions from Amgen. The language buried in Section 632 of the law delays a set of Medicare price restraints on a class of drugs that includes Sensipar, a lucrative Amgen pill used by kidney dialysis patients.
The provision gives Amgen an additional two years to sell Sensipar without government controls. The news was so welcome that the company’s chief executive quickly relayed it to investment analysts. But it is projected to cost Medicare up to $500 million over that period.
Originally posted by Wrabbit2000
After all the waivers and exemptions given out over Obamacare in both temp and perm. forms, you almost wonder who is left to follow the whole thing? It seems just us suckers who don't have any special interests to win waivers for.
Isn't being an average citizen supposed to be the ultimate special interest group? I know... Silly of me. That's the old America in our (not so) distant past,